Syndication Nation — Will rescheduling light up the cannabis debt markets?

Hemp, hemp, hooray! The cannabis industry rejoiced earlier this year when the Department of Justice officially reclassified state-licensed medical marijuana from Schedule I to Schedule III — placing it in the same category as testosterone, rather than heroin.

But the real game-changer for the industry would be expanding Schedule III status to adult-use recreational cannabis, which the DOJ reviewed during formal administrative hearings in July. A broader reclassification would potentially pave the way for more tax relief, as well as additional collateral and financing options for stressed cannabis borrowers.

LevFin editor Bill Weisbrod grinds down the situation with deputy LevFin editor Sasha Padbidri in this episode of Cloud 9fin’s Syndication Nation.

Have any feedback for us? Send us a note at podcast@9fin.com. Thanks for listening!